Federal contract award
HHSO100200900106C
BIOMEDICAL (ADVANCED)
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 325414 — Biological Product (except Diagnostic) Manufacturing |
| PSC | AN13 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $146.7M |
| Current contract value | $262.6M |
| Potential contract value / ceiling | $507.6M |
| Start date | Jun 21, 2009 |
| Current end date | Dec 31, 2016 |
| Potential end date | Dec 31, 2016 |
| Latest award activity | Sep 9, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 11 of 11 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 9, 2026 | P00010 | $-192.1K | ADVANCED DEVELOPMENT OF RECOMBINANT INFLUENZA VACCINE. |
| Dec 16, 2016 | 9 | $0 | SEE SECOND PAGE FOR DESCRIPTION |
| Sep 23, 2016 | 8 | $0 | SEE SECOND PAGE FOR DESCRIPTION |
| Jan 8, 2016 | 7 | $0 | SEE SECOND PAGE FOR DESCRIPTION |
| Aug 22, 2014 | 6 | $0 | SEE SECOND PAGE FOR DESCRIPTION |
| Jun 9, 2014 | 5 | $50.6M | MODIFICATION 0011 |
| Mar 26, 2014 | 4 | $0 | MOD 0009 |
| May 2, 2013 | 3 | $15.0M | BIOMEDICAL (ADVANCED) |
| May 16, 2011 | 2 | $46.8M | BIOMEDICAL (ADVANCED) |
| Sep 17, 2009 | 1 | $0 | BIOMEDICAL (ADVANCED) |
| Jun 21, 2009 | 0 | $34.5M | BIOMEDICAL (ADVANCED) |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.